These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

670 related items for PubMed ID: 27989322

  • 41. Liver transplantation for aHUS: still needed in the eculizumab era?
    Coppo R, Bonaudo R, Peruzzi RL, Amore A, Brunati A, Romagnoli R, Salizzoni M, Galbusera M, Gotti E, Daina E, Noris M, Remuzzi G.
    Pediatr Nephrol; 2016 May; 31(5):759-68. PubMed ID: 26604087
    [Abstract] [Full Text] [Related]

  • 42. Blocking Properdin Prevents Complement-Mediated Hemolytic Uremic Syndrome and Systemic Thrombophilia.
    Ueda Y, Miwa T, Gullipalli D, Sato S, Ito D, Kim H, Palmer M, Song WC.
    J Am Soc Nephrol; 2018 Jul; 29(7):1928-1937. PubMed ID: 29858280
    [Abstract] [Full Text] [Related]

  • 43. A haplotype in CFH family genes confers high risk of rare glomerular nephropathies.
    Ding Y, Zhao W, Zhang T, Qiang H, Lu J, Su X, Wen S, Xu F, Zhang M, Zhang H, Zeng C, Liu Z, Chen H.
    Sci Rep; 2017 Jul 20; 7(1):6004. PubMed ID: 28729648
    [Abstract] [Full Text] [Related]

  • 44. The complement system in the pathogenesis and progression of kidney diseases: What doesn't kill you makes you older.
    Stea ED, D'Ettorre G, Mitrotti A, Gesualdo L.
    Eur J Intern Med; 2024 Jun 20; 124():22-31. PubMed ID: 38461065
    [Abstract] [Full Text] [Related]

  • 45. Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement.
    Song D, Yu XJ, Wang FM, Xu BN, He YD, Chen Q, Wang SX, Yu F, Song WC, Zhao MH.
    Am J Reprod Immunol; 2015 Oct 20; 74(4):345-56. PubMed ID: 26011580
    [Abstract] [Full Text] [Related]

  • 46. A rare case of Alport syndrome, atypical hemolytic uremic syndrome and Pauci-immune crescentic glomerulonephritis.
    Tao J, Lieberman J, Lafayette RA, Kambham N.
    BMC Nephrol; 2018 Dec 12; 19(1):355. PubMed ID: 30541482
    [Abstract] [Full Text] [Related]

  • 47. Recurrent Glomerular Disease after Kidney Transplantation: Diagnostic and Management Dilemmas.
    Uffing A, Hullekes F, Riella LV, Hogan JJ.
    Clin J Am Soc Nephrol; 2021 Nov 12; 16(11):1730-1742. PubMed ID: 34686531
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Atypical haemolytic uremic syndrome (aHUS) and membranoproliferative glomerulonephritis (MPGN), different diseases or a spectrum of complement-mediated glomerular diseases?
    Ankawi GA, Clark WF.
    BMJ Case Rep; 2017 Aug 10; 2017():. PubMed ID: 28798244
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Atypical Hemolytic Uremic Syndrome: New Challenges in the Complement Blockage Era.
    Avila Bernabeu AI, Cavero Escribano T, Cao Vilarino M.
    Nephron; 2020 Aug 10; 144(11):537-549. PubMed ID: 32950988
    [Abstract] [Full Text] [Related]

  • 53. Glomerular Diseases Dependent on Complement Activation, Including Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, and C3 Glomerulopathy: Core Curriculum 2015.
    Noris M, Remuzzi G.
    Am J Kidney Dis; 2015 Aug 10; 66(2):359-75. PubMed ID: 26032627
    [No Abstract] [Full Text] [Related]

  • 54. Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome.
    Fang CJ, Fremeaux-Bacchi V, Liszewski MK, Pianetti G, Noris M, Goodship TH, Atkinson JP.
    Blood; 2008 Jan 15; 111(2):624-32. PubMed ID: 17914026
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Anti-complement-factor H-associated glomerulopathies.
    Durey MA, Sinha A, Togarsimalemath SK, Bagga A.
    Nat Rev Nephrol; 2016 Sep 15; 12(9):563-78. PubMed ID: 27452363
    [Abstract] [Full Text] [Related]

  • 60. Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
    Yuan X, Gavriilaki E, Thanassi JA, Yang G, Baines AC, Podos SD, Huang Y, Huang M, Brodsky RA.
    Haematologica; 2017 Mar 15; 102(3):466-475. PubMed ID: 27810992
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.